Bioorthogonal labeling cell-surface proteins expressed in pancreatic cancer cells to identify potential diagnostic/therapeutic biomarkers
| العنوان: | Bioorthogonal labeling cell-surface proteins expressed in pancreatic cancer cells to identify potential diagnostic/therapeutic biomarkers |
|---|---|
| المؤلفون: | Charles M. Quick, Ilangovan Raju, Eric R. Siegel, Randy S. Haun, Alan J. Tackett, Samuel G. Mackintosh |
| المصدر: | Cancer Biology & Therapy. 16:1557-1565 |
| بيانات النشر: | Informa UK Limited, 2015. |
| سنة النشر: | 2015 |
| مصطلحات موضوعية: | Pharmacology, Gel electrophoresis, chemistry.chemical_classification, Cancer Research, Chemistry, Membrane Proteins, medicine.disease, Research Papers, Molecular biology, Pancreatic Neoplasms, Bioorthogonal chemical reporter, chemistry.chemical_compound, Oncology, Biotin, Cell culture, Pancreatic cancer, Biomarkers, Tumor, medicine, Humans, Molecular Medicine, Immunohistochemistry, Bioorthogonal chemistry, Glycoprotein |
| الوصف: | To develop new diagnostic and therapeutic tools to specifically target pancreatic tumors, it is necessary to identify cell-surface proteins that may serve as potential tumor-specific targets. In this study we used an azido-labeled bioorthogonal chemical reporter to metabolically label N-linked glycoproteins on the surface of pancreatic cancer cell lines to identify potential targets that may be exploited for detection and/or treatment of pancreatic cancer. Labeled glycoproteins were tagged with biotin using click chemistry, purified by streptavidin-coupled magnetic beads, separated by gel electrophoresis, and identified by liquid chromatography-tandem mass spectrometry (MS). MS/MS analysis of peptides from 3 cell lines revealed 954 unique proteins enriched in the azido sugar samples relative to control sugar samples. A comparison of the proteins identified in each sample indicated 20% of these proteins were present in 2 cell lines (193 of 954) and 17 of the proteins were found in all 3 cell lines. Five of the 17 proteins identified in all 3 cell lines have not been previously reported to be expressed in pancreatic cancer; thus indicating that novel cell-surface proteins can be revealed through glycoprotein profiling. Western analysis of one of these glycoproteins, ecto-5'-nucleotidase (NT5E), revealed it is expressed in 8 out of 8 pancreatic cancer cell lines examined. Further, immunohistochemical analysis of human pancreatic tissues indicates NT5E is significantly overexpressed in pancreatic tumors compared to normal pancreas. Thus, we have demonstrated that metabolic labeling with bioorthogonal chemical reporters can be used to selectively enrich and identify novel cell-surface glycoproteins expressed in pancreatic ductal adenocarcinomas. |
| تدمد: | 1555-8576 1538-4047 |
| الوصول الحر: | https://explore.openaire.eu/search/publication?articleId=doi_dedup___::da0c09ae9abb160585967537424b4f31Test https://doi.org/10.1080/15384047.2015.1071740Test |
| حقوق: | OPEN |
| رقم الانضمام: | edsair.doi.dedup.....da0c09ae9abb160585967537424b4f31 |
| قاعدة البيانات: | OpenAIRE |
| تدمد: | 15558576 15384047 |
|---|